$28.34
0.21%
Nasdaq, Apr 21, 08:45 pm CET
ISIN
US4622221004
Symbol
IONS
Sector
Industry

Ionis Pharmaceuticals, Inc. Stock price

$28.40
-5.90 17.20% 1M
-10.09 26.21% 6M
-6.56 18.76% YTD
-12.51 30.58% 1Y
-12.61 30.75% 3Y
-26.67 48.43% 5Y
-36.93 56.53% 10Y
Nasdaq, Closing price Thu, Apr 17 2025
+0.05 0.18%
ISIN
US4622221004
Symbol
IONS
Sector
Industry

Key metrics

Market capitalization $4.51b
Enterprise Value $4.17b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 5.91
P/S ratio (TTM) P/S ratio 6.40
P/B ratio (TTM) P/B ratio 7.62
Revenue growth (TTM) Revenue growth -10.48%
Revenue (TTM) Revenue $705.56m
EBIT (operating result TTM) EBIT $-474.26m
Free Cash Flow (TTM) Free Cash Flow $-546.23m
Cash position $2.30b
EPS (TTM) EPS $-3.04
P/E forward negative
P/S forward 6.96
EV/Sales forward 6.43
Short interest 9.78%
Show more

Is Ionis Pharmaceuticals, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.

Ionis Pharmaceuticals, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

27 Analysts have issued a Ionis Pharmaceuticals, Inc. forecast:

18x Buy
67%
8x Hold
30%
1x Sell
4%

Analyst Opinions

27 Analysts have issued a Ionis Pharmaceuticals, Inc. forecast:

Buy
67%
Hold
30%
Sell
4%

Financial data from Ionis Pharmaceuticals, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
706 706
10% 10%
100%
- Direct Costs 33 33
6% 6%
5%
672 672
11% 11%
95%
- Selling and Administrative Expenses 223 223
19% 19%
32%
- Research and Development Expense 901 901
0% 0%
128%
-452 -452
37% 37%
-64%
- Depreciation and Amortization 22 22
2% 2%
3%
EBIT (Operating Income) EBIT -474 -474
34% 34%
-67%
Net Profit -454 -454
24% 24%
-64%

In millions USD.

Don't miss a Thing! We will send you all news about Ionis Pharmaceuticals, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Ionis Pharmaceuticals, Inc. Stock News

Neutral
Business Wire
18 days ago
CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today it will host a webinar on Monday, April 14th at 11:00 a.m. ET focused on the risks, clinical presentation and significant unmet medical needs associated with severe hypertriglyceridemia (sHTG). Key thought leaders in lipidology, cardiology and endocrinology will join Sam Tsimikas, M.D., senior vice pre...
Neutral
Business Wire
21 days ago
CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences: 24th Annual Needham Virtual Healthcare Conference on Monday, April 7, 2025 Bank of America 2025 Health Care Conference on Wednesday, May 14, 2025 2025 RBC Capital Markets Global Healthcare Conference on Wednesday,...
Neutral
Business Wire
26 days ago
CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that it has entered into a license agreement under which Sobi® receives exclusive rights in countries outside the U.S., Canada and China to commercialize olezarsen as a potential treatment for familial chylomicronemia syndrome (FCS) and severely elevated triglycerides. Ionis will continue to independen...
More Ionis Pharmaceuticals, Inc. News

Company Profile

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.

Head office United States
CEO Brett Monia
Employees 1,069
Founded 1989
Website www.ionis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today